Women in their 70s and 80s who were exposed to higher levels of air pollution experienced greater declines in memory and more Alzheimer's-like brain atrophy than their counterparts who breathed cleaner air, according to USC researchers.
A recent study published in Muscle & Nerve appears to show that the influenza vaccination is safe to use for those with autoimmune neuromuscular disorders.
BrainStorm Cell Therapeutics Inc., a leader in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, today announced publication of "NurOwn Phase 2 Randomized Clinical Trial in ALS: Safety, Clinical and BioMarker Results," in the international, peer-reviewed journal Neurology.
Worldwide, more than 15 million women of childbearing age have epilepsy. Each year about 600,000 of them become pregnant.
November is national Lung Cancer Awareness Month. Lung cancer remains the #1 cancer killer of both men and women in the United States.
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis.
People with prosopagnosia, or "face blindness," have trouble recognizing faces -- even those of close friends and family members.
Mount Sinai Kravis Children's Hospital announced today that it has partnered with the Bezos Family Foundation and Vroom, the Foundation's early learning program.
Northwestern Medicine scientists have discovered a new phenomenon in the brain that could explain the development of early stages of neurodegeneration seen in diseases such as ALS, which affects voluntary muscle movement such as walking and talking.
A study has shown that one in two Americans between age 50 and 64 years is aware of the risk of development of dementia with age but only 5 percent are actually visiting their healthcare providers to seek preventive and therapeutic attention.